353 related articles for article (PubMed ID: 9556067)
1. Cathepsin K mRNA detection is restricted to osteoclasts during fetal mouse development.
Dodds RA; Connor JR; Drake F; Feild J; Gowen M
J Bone Miner Res; 1998 Apr; 13(4):673-82. PubMed ID: 9556067
[TBL] [Abstract][Full Text] [Related]
2. Human osteoclast and giant cell differentiation: the apparent switch from nonspecific esterase to tartrate resistant acid phosphatase activity coincides with the in situ expression of osteopontin mRNA.
Connor JR; Dodds RA; James IE; Gowen M
J Histochem Cytochem; 1995 Dec; 43(12):1193-201. PubMed ID: 8537635
[TBL] [Abstract][Full Text] [Related]
3. Expression of cathepsin K messenger RNA in giant cells and their precursors in human osteoarthritic synovial tissues.
Dodds RA; Connor JR; Drake FH; Gowen M
Arthritis Rheum; 1999 Aug; 42(8):1588-93. PubMed ID: 10446855
[TBL] [Abstract][Full Text] [Related]
4. Human osteoclasts, not osteoblasts, deposit osteopontin onto resorption surfaces: an in vitro and ex vivo study of remodeling bone.
Dodds RA; Connor JR; James IE; Rykaczewski EL; Appelbaum E; Dul E; Gowen M
J Bone Miner Res; 1995 Nov; 10(11):1666-80. PubMed ID: 8592943
[TBL] [Abstract][Full Text] [Related]
5. Expression of tartrate-resistant acid phosphatase and cathepsin K during osteoclast differentiation in developing mouse mandibles.
Nakamura M; Aoyama N; Yamaguchi S; Sasano Y
Biomed Res; 2021; 42(1):13-21. PubMed ID: 33563875
[TBL] [Abstract][Full Text] [Related]
6. Expression analysis of nha-oc/NHA2: a novel gene selectively expressed in osteoclasts.
Pham L; Purcell P; Morse L; Stashenko P; Battaglino RA
Gene Expr Patterns; 2007 Oct; 7(8):846-51. PubMed ID: 17698421
[TBL] [Abstract][Full Text] [Related]
7. Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor.
Gravallese EM; Manning C; Tsay A; Naito A; Pan C; Amento E; Goldring SR
Arthritis Rheum; 2000 Feb; 43(2):250-8. PubMed ID: 10693863
[TBL] [Abstract][Full Text] [Related]
8. Proteolytic processing and polarized secretion of tartrate-resistant acid phosphatase is altered in a subpopulation of metaphyseal osteoclasts in cathepsin K-deficient mice.
Zenger S; Hollberg K; Ljusberg J; Norgård M; Ek-Rylander B; Kiviranta R; Andersson G
Bone; 2007 Nov; 41(5):820-32. PubMed ID: 17765026
[TBL] [Abstract][Full Text] [Related]
9. Localization of cathepsin K in human osteoclasts by in situ hybridization and immunohistochemistry.
Littlewood-Evans A; Kokubo T; Ishibashi O; Inaoka T; Wlodarski B; Gallagher JA; Bilbe G
Bone; 1997 Feb; 20(2):81-6. PubMed ID: 9028530
[TBL] [Abstract][Full Text] [Related]
10. Mouse cathepsin K: cDNA cloning and predominant expression of the gene in osteoclasts, and in some hypertrophying chondrocytes during mouse development.
Rantakokko J; Aro HT; Savontaus M; Vuorio E
FEBS Lett; 1996 Sep; 393(2-3):307-13. PubMed ID: 8814310
[TBL] [Abstract][Full Text] [Related]
11. Parathyroid hormone-related protein is required for normal intramembranous bone development.
Suda N; Baba O; Udagawa N; Terashima T; Kitahara Y; Takano Y; Kuroda T; Senior PV; Beck F; Hammond VE
J Bone Miner Res; 2001 Dec; 16(12):2182-91. PubMed ID: 11760831
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-17A induces cathepsin K and MMP-9 expression in osteoclasts via celecoxib-blocked prostaglandin E2 in osteoblasts.
Zhang F; Tanaka H; Kawato T; Kitami S; Nakai K; Motohashi M; Suzuki N; Wang CL; Ochiai K; Isokawa K; Maeno M
Biochimie; 2011 Feb; 93(2):296-305. PubMed ID: 20937352
[TBL] [Abstract][Full Text] [Related]
13. Osteoclast markers accumulate on cells developing from human peripheral blood mononuclear precursors.
Faust J; Lacey DL; Hunt P; Burgess TL; Scully S; Van G; Eli A; Qian Y; Shalhoub V
J Cell Biochem; 1999 Jan; 72(1):67-80. PubMed ID: 10025668
[TBL] [Abstract][Full Text] [Related]
14. Quantification of the expression levels of lysosomal cysteine proteinases in purified human osteoclastic cells by competitive RT-PCR.
Ishibashi O; Inui T; Mori Y; Kurokawa T; Kokubo T; Kumegawa M
Calcif Tissue Int; 2001 Feb; 68(2):109-16. PubMed ID: 11310346
[TBL] [Abstract][Full Text] [Related]
15. Generation of mouse osteoclastogenic cell lines immortalized with SV40 large T antigen.
Chen W; Li YP
J Bone Miner Res; 1998 Jul; 13(7):1112-23. PubMed ID: 9661075
[TBL] [Abstract][Full Text] [Related]
16. Expression of the calcitonin receptor in bone marrow cell cultures and in bone: a specific marker of the differentiated osteoclast that is regulated by calcitonin.
Lee SK; Goldring SR; Lorenzo JA
Endocrinology; 1995 Oct; 136(10):4572-81. PubMed ID: 7664679
[TBL] [Abstract][Full Text] [Related]
17. Everolimus suppresses cancellous bone loss, bone resorption, and cathepsin K expression by osteoclasts.
Kneissel M; Luong-Nguyen NH; Baptist M; Cortesi R; Zumstein-Mecker S; Kossida S; O'Reilly T; Lane H; Susa M
Bone; 2004 Nov; 35(5):1144-56. PubMed ID: 15542040
[TBL] [Abstract][Full Text] [Related]
18. Identification and characterization of the new osteoclast progenitor with macrophage phenotypes being able to differentiate into mature osteoclasts.
Takeshita S; Kaji K; Kudo A
J Bone Miner Res; 2000 Aug; 15(8):1477-88. PubMed ID: 10934646
[TBL] [Abstract][Full Text] [Related]
19. Cathepsin K, but not cathepsins B, L, or S, is abundantly expressed in human osteoclasts.
Drake FH; Dodds RA; James IE; Connor JR; Debouck C; Richardson S; Lee-Rykaczewski E; Coleman L; Rieman D; Barthlow R; Hastings G; Gowen M
J Biol Chem; 1996 May; 271(21):12511-6. PubMed ID: 8647859
[TBL] [Abstract][Full Text] [Related]
20. The mineral dissolution function of osteoclasts is dispensable for hypertrophic cartilage degradation during long bone development and growth.
Touaitahuata H; Cres G; de Rossi S; Vives V; Blangy A
Dev Biol; 2014 Sep; 393(1):57-70. PubMed ID: 24992711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
